Medartis AG

Swiss quality since 1997

Medartis AG, headquartered in Basel, is a manufacturer of medical devices for the surgical fixation and joint replacement of bone fractures in the upper and lower extremities as well as in the craniomaxillofacial region. The company, founded in 1997 by Dr. h.c. Thomas Straumann, manufactures titanium implants such as osteosynthesis plates and screws, with its own production facility established in Bretzwil in 2005. Through the CMX service, patient-specific implants, guides, bone models and positioning aids are manufactured on the basis of CT data via 3D printing or 3D milling and delivered within 5–10 working days. With around 1,200 employees at 13 locations, Medartis supplies more than 50 countries worldwide; in addition to Basel and Bretzwil, production sites exist in Warsaw (Indiana, USA), Archamps and Besançon (France) and Curitiba (Brazil). The subsidiary Medartis GmbH in Umkirch handles distribution and acts as the authorized representative for the EU.

Site

Basel

Processes

3D printing of personalized CMX implants, guides, bone models and, Manufacture of osteosynthesis plates and screws (in-house production), 3D-milled patient-specific plates (custom 3D milled plate), Sterile packaging (in-house process), CMX: patient-specific implants, guides, bone models and positioning aids (3D printing), CMX Portal: web-based case management (case planning, 3D visualization, communication, approval,, Personal 3D preoperative planning by the CMX Designer, Production and shipping of personalized instruments within 5–10 working days

Materials

Titanium, Additive Manufacturing, 3D-milled plates, Sterile Packaging

Certificates

EN ISO 13485:2016 + AC:2018 + A11:2021, EU MDR Regulation (EU) 2017/745 (NB 0197), UKCA Certificate - Full Quality Assurance System, EN ISO 13485:2016, EU MDR 2017/745, UKCA (BSI)

Founded

1997

Employees

ca. 1,200

Industries

Medical technology / orthopedic surgery (upper and lower extremities), Craniomaxillofacial surgery (CMF), Joint replacement

1. 01

   CT data capture and upload via CMX Portal

2. 02

   3D preoperative planning by the CMX Designer

3. 03

   Approval of the design by the surgeon (binding order)

4. 04

   3D printing / CNC milling of the patient-specific implants and instruments

5. 05

   Series production of plates and screws (Basel, Bretzwil, Warsaw,

6. 06

   Sterile packaging (in-house)

7. 07

   Delivery with case documentation within 5–10 working days

Materials and Technologies

Locations

Basel

CH

Headquarters, Research & Development, Production

Materials

Titanium

Bretzwil

CH

Production site (screws and plates, since 2005)

Materials

Titanium

Warsaw (Indiana)

USA

Development and production site (since 2022, Nextremity Solutions Inc.)

Materials

Titanium

Umkirch

DE

Subsidiary Medartis GmbH: sales and authorized representative (distribution of CMF and orthopedic

Archamps

FR

Production site (through KeriMedical acquisition 2025)

Besançon

FR

Production site (through KeriMedical acquisition 2025)

Curitiba

BR

Production site (majority stake in NeoOrtho, 2025)

Components and Products

Inside the production

Processes & technical limits

Quality and Certificates

Medartis maintains a quality management system certified to EN ISO 13485:2016 (TÜV Rheinland, no. SX 1809678-1) and is approved under EU MDR 2017/745 (Notified Body 0197) as well as UKCA (BSI). The approval covers the design, manufacture and distribution of CMF and orthopedic implants as well as personalized instruments produced using 3D printing processes.

History

1. 1954

   Founding of Institut Straumann AG by Prof. Dr. Reinhard Straumann (metallurgy for the watchmaking industry)

2. 1960

   Fritz Straumann develops, together with engineers, the first internal fixation implant

3. 1990

   Sale of the orthopedics business 'Synthes' to Rudolf Maag; re-establishment as Stratec Medical

4. 1997

   Founding of Medartis AG with headquarters in Basel by Dr. h.c. Thomas Straumann

5. 2002

   Direct distribution of the implants; founding of subsidiaries (including Umkirch, Vienna, Lyon, Batley, Philadelphia)

6. 2004

   Launch of TriLock (multidirectional angle-stable locking system) and APTUS; co-founding of IBRA in Zurich

7. 2005

   Own production facility in Bretzwil (Basel-Land); launch of the first Distal Radius System 2.5

8. 2008

   Launch of SpeedTip screw technology and HexaDrive

9. 2009

   Move to the Stücki Business Park, Basel-Kleinhüningen

10. 2010

    Expansion into lower extremities (foot/ankle) and elbow

11. 2011

    Introduction of cannulated compression screws 2.2/3.0 and the wrist arthrodesis system 2.5

12. 2015

    Launch of the new Radius System 2.5 (including ADAPTIVE II plates)

13. 2016

    Foot/ankle expansion: Hallux System 2.8, SpeedTip C 2.0/2.8, CCS Extension

14. 2017

    Acquisition of Mimedis (preoperative planning and 3D printing of patient-specific implants)

15. 2018

    IPO on 23.03.2018, market value approx. CHF 600 million

16. 2022

    Acquisition of Nextremity Solutions Inc., Warsaw, Indiana, USA (production floor space 6,500 m²)

17. 2023

    Celebration of the 1 millionth Distal Radius plate system sold

18. 2024

    Matthias Schupp becomes CEO (November 2024)

19. 2025

    Acquisition of 51% majority stakes in NeoOrtho (Brazil) and full acquisition of KeriMedical (Geneva, with production sites in Archamps and Besançon, France)

20. 2026

    Swiss Medtech Award 2026; acquisition of the M.A.R.C. Institute, Doral, Florida; H1 2026 revenue CHF 160.8 million, organic growth 17.0%, EBITDA margin 18.0%